These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 6322976

  • 1. Inhibition of herpes simplex virus replication by purine deoxyribonucleosides.
    North TW.
    Cancer Res; 1984 Apr; 44(4):1415-9. PubMed ID: 6322976
    [Abstract] [Full Text] [Related]

  • 2. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
    Ross DD, Akman SA, Schrecker AW, Bachur NR.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
    [Abstract] [Full Text] [Related]

  • 3. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
    Wilson JM, Mitchell BS, Daddona PE, Kelley WN.
    J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
    [Abstract] [Full Text] [Related]

  • 4. Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.
    North TW, Cohen SS.
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4684-8. PubMed ID: 216993
    [Abstract] [Full Text] [Related]

  • 5. Regulatory effects of deoxyribonucleosides on the activity of 5-methoxymethyl-2'-deoxycytidine: modulation of antiherpes activity by deoxyguanosine and tetrahydrodeoxyuridine.
    Aduma PJ, Gupta SV, Stuart AL, Tourigny G.
    Antiviral Res; 1991 May; 15(4):301-13. PubMed ID: 1659312
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preferential inhibition of 5-trifluoromethyl-2'-deoxyuridine phosphorylation by 5'-amino-5'-deoxythymidine in uninfected versus herpes simplex virus-infected cells.
    Fischer PH, Murphy DG, Kawahara R.
    Mol Pharmacol; 1983 Jul; 24(1):90-6. PubMed ID: 6408395
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adenosine deaminase impairment and ribonucleotide reductase activity and levels in HeLa cells.
    Lin AL, Elford HL.
    J Biol Chem; 1980 Sep 25; 255(18):8523-8. PubMed ID: 6997299
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of Newcastle disease virus replication by 6-azauridine. II. Combination of 6-azauridine and adenine derivatives.
    Rada B, Dragún M.
    Acta Virol; 1976 Apr 25; 20(2):102-6. PubMed ID: 5863
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.